{"instruction": "Create a comprehensive study guide for Tuberculosis (TB) optimized for medical exam preparation.", "input": "Topic: Tuberculosis (TB)", "output": "- ## Primary (pulmonary) TB\n    - epidemiology >>>\n        - Global prevalence\n        - High incidence in low-income countries\n        - Incidence rates higher in specific populations (e.g., HIV-positive individuals)\n        - Risk factors: immunocompromised, crowded living conditions\n        - Transmission via airborne droplets\n    - 3 big killers >>>\n        - TB, HIV, Malaria - in children & immunodeficient \n    - etiology >>>\n        - Mycobacterium TB complex: M.tuberculosis, africanum, Bovis (â†‘mortality, + assoc. w/ HIV)\n        - cell wall - major virulence factor - resist environmental factors\n        - â†‘ replication â‰  slow cultures\n    - pathology >>>\n        - airborne transmission - infectious droplet nuclei - remain aerosolized for a few hours\n        - extrapulmonary TB = not contagious\n        - 90% expelled by ciliary system\n        - most of remaining, phagocytized by macroph. â‡’ replicate â‡’ granuloma formation\n        - granuloma\n            - central zone; caseous necrosis\n            - intermediate; macroph. & monocytes\n            - external; giant multinucleated cells - barrier to Mycobactect. spread\n        - DD granuloma biopsy (possible other diagnosis from granuloma biopsy):\n            - NTM, sarcoidosis, fungal infections, lymphoma\n    - symptoms >>>\n        - chronic course - 10-20% asymptomatic\n        - non-specific extrapulm. sympt: fever, fatigue, anorexia\n        - chest symptoms: pleural/thoracic pain, productive cough, hemoptysis (late symptom)\n        - primary progressive TB - lymph node enlargement â‡’ may involve into miliary form (disseminated) / CNS\n    - diagnosis >>>\n        - suspicion & clinical features\n        - microbiological diagnosis:\n            - staining - acid fast - quick, but when higher load/more contagious\n            - PCR - quick, medium/high sensitivity - detects dead mycobacteria too\n            - culture (gold standard) - high sensitivity, but slow (might need to treat before results)\n            - lipoarabinomannan (LAM) - component of cell wall - detected in urine, highly sensitive, cheap\n    - treatment >>>\n        - isolation if suspect\n        - standard therapy: 2 months isoniazid, rifampicin and other combo â‡’ then, 4 months only isoniazid & rifampicin\n        - multiple drug regimen - to avoid resistance\n- \n- \n- ## latent TB\n    - epidemiology >>>\n        - immunocompetent - mycobact. replicate in macroph.\n        - 95% maintain immune control - 5% reactivates\n    - pathology >>>\n        - granuloma - calcification â‡’ scarring\n    - symptoms >>>\n        - silent, asymptomatic\n        - not contagious\n    - diagnosis >>>\n        - Tuberculin skin test (TST) - Mantoux\n            - after 72h, positive if bigger than 10mm\n        - Interferon-gamma release assays (IGRAs)\n            - higher sensitivity but expensive\n            - doesnt differentiate active VS latent TB, or other infections\n    - treatment >>>\n        - PET CT + biopsy â‡’ to predict reactivation risk (lung nodules)\n        - categories for preventive therapy:\n            - HIV+, recent exposure, organ transplant, immunosuppressed, ppl from high prevalence countries, lab personnel\n        - 3 months of isoniazid + rifampicin\n- \n- \n- ## Extra-pulmonary TB\n    - extra-pulmonary TB - examples >>>\n        - miliary/disseminated \n        - Lymphadenitis \n        - Serositis â€’ Pleuritis, Pericarditis \n        - CNS meningitis \n        - genitourinary \n    - \n    - miliary/disseminated >>>\n        - metastatic lesions of mycobacteria\n        - acute, rapidly evolving - fever, dyspnea, hypoxemia\n        - Xray - nodular pattern in interstitium\n        - negative sputum staining, BAL, Mantoux - so difficult diagnosis\n        - PCR better for diagnosis\n    - Lymphadenitis >>>\n        - most common extrapulm. TB in children & immunosuppressed\n        - commonly affect nodes: infraclavicular, lateral, cervical\n        - non painful, soft lymph nodes\n        - positive Mantoux, PCR\n        - biopsy for better diagnosis\n        - DD: NTM, lymphomas, metastatic tumors, toxoplasma\n    - Serositis\n        - Pleuritis >>>\n            - pain pleural effusion\n            - thoracentesis for diagnosis - lymphocytes found - not specific for TB though\n            - negative/low sensitivity stvisaining, PCR, culture\n        - Pericarditis >>>\n            - subacute\n            - fever, pain, tachycardia, ECG alterations\n            - US: pericardial effusion\n            - complications: cardiac tamponade\n    - CNS (meningitis) >>>\n        - altered CSF circulation â‡’ hydrocephalus â‡’ ventricles enlargement\n        - slow onset: headache, fever, weight loss, cranial nerve palsies\n        - sudden onset: vasculitis lesions\n        - CTI/MRI - tuberculomas\n        - CSF - â†“ GLUCOSE \n        - negative/low sensitivity to staining, PCR, culture\n        - longer standard therapy\n    - genitourinary >>>\n        - urinary TB\n            - 2nd most common extrapulm. TB\n            - hematogenous spread â‡’ chronic pyelonephritis\n            - sterile pyuria - â†‘ leukocytes but negative culture\n        - Genital TB\n            - men: urethritis, superficial ulcer, chronic epididymitis\n            - woman: strictures, infertility\n- \n- \n- ## IRIS\n    - IRIS >>>\n        - immune Reconstitution Inflammatory Syndrome\n        - paradoxical inflammation against a foreign antigen in patients who have started ART (co-infection w/ HIV)\n    - RF >>>\n        - bacterial load\n        - dissemination besides lungs\n    - pathology >>>\n        - ARV treatment â‡’ restoration of immune response\n        - majority of opportunistic infections = treated 10-14gg before ARV\n        - exception: TB, cryptococcal meningitis (ARV after over 6 weeks post-treatment)\n    - diagnosis >>>\n        - screen for opportunistic infections before ARV treatment\n        - **unmasking IRIS**\n            - opportunistic infection develops after ARV treatment\n        - **worsening IRIS**\n            - pre-existing opportunistic infection worsens w/ ARV\n    - treatment >>>\n        - interrupt ARV if unmasking\n        - NSAIDs/Corticosteroids if worsening\n        - prevention of TB-associated IRIS (patients w/ HIV + TB) â‡’ prednisone (glucocorticoid for immune suppression)\n-", "task_type": "study_guide_generation", "subject": "infectious_diseases", "topic": "tuberculosis"}
{"instruction": "Create a comprehensive study guide for HIV optimized for medical exam preparation.", "input": "Topic: HIV", "output": "- history >>>\n    - 1st identified in 1981 in USA after some homosexual men presented w/ rare Pneumocystis carinii pneumonia (PCP) & Kaposi's sarcoma - both indicative of severe immunosuppression\n    - 1983 virus was isolated by French researchers who later got Nobel Prize\n    - is believed to have originated from Simian Immunodeficiency Virus in Central Africa via zoonotic spillover - prob in early 20th century\n    - 1987 first antiretroviral drug zidovudine\n    - 1996 development of HAART (highly active antiretroviral therapy) - transforming HIV from fatal disease to chronic condition\n- structure >>>\n    - retrovirus w/ lipid envelope, matrix, capsid\n    - 2 RNA molecules\n    - 3 key enzymes - reverse transcriptase, integrase, protease (cleaves viral polyproteins into functional proteins) - each enzyme is a target for specific antiretroviral drugs\n    - viral envelope contains glycoproteins gp120 & gp41 - for viral entry into host cell\n    - genome includes structural proteins (gag, pol), regulatory proteins, & accessory proteins\n- classification >>>\n    - belongs to Lentivirus genus of Retroviridae family\n    - 2 main phylogenetic types: HIV-1 & HIV-2 - genetic diversity determines effectiveness of diagnostic & treatment strategies\n- glycoproteins >>>\n    - gp120 mediates attachment to host cell receptor CD4\n    - gp41 mediates fusion of viral & host cell membranes\n    - interaction between gp120 7 CD4 is highly specific, involving coreceptors CCR5 or CXCR4 - can create viral inhibitors for antiretrovirals\n- HIV-2 >>>\n    - less pathogenic & less easily transmitted than HIV-1\n    - primarilly found in West Africa\n    - HIV-2 has slower rate of disease progression & is associated w/ lower viral load\n- HIV  Life cycle >>>\n    - attachment - viral gp120 binds to host cell CD4 r. - target of some antiretrovirals\n    - fusion - viral gp41 meidates fusion - fusion inhibitors for retrovirals\n    - reverse transcription - reverse transcriptase converts viral RNA â‡’ to dsDNA -reverse transcriptase inhibitors \n    - integration - integrase integrates viral DNA into host cell genome - integrase inhibitors\n    - transcription - viral DNA transcribed into viral RNA - target of some antiretrovirals\n    - translation - viral RNA translated into viral proteins - translation inhibitors\n    - assembly - viral proteins & RNA assemble into new virions - assembly inhibitors \n    - budding - new virions bud from host cell membrane - budding inhibitors\n    - maturation - viral protease cleaves viral polyproteins into functional proteins - protease inhibitors preventing maturation\n    - combination antiretroviral therapy (cART) uses multiple drugs to minimize development of drug resistance\n- HIV transmission >>>\n    - transmission routes - sexual contact (vaginal, anal, oral), blood-borne (blood transfusions, needle sharing), vertical (pregnancy, childbirth, breastfeeding)\n    - risk of transmission vaires depending on route of exposure, viral load, presence of other STIs\n- Risk Factors >>>\n    - multiple sex partners\n    - unprotected sex\n    - IV drug use\n    - blood transfusions before 1985 (before Ag tests)\n    - mother-to-child transmission\n    - understanding RF, is crucial for effective prevention strategies\n- epidemiology >>>\n    - millions of people live w/ HIV \n    - highest prevalance in sub-Saharan Africa\n    - key populations: MSM, ppl who inject drugs, transgender women, sex workers - require targeted prevention & treatment\n    - cascade of care 95-95-95: public health strategy aiming for 95% of ppl w/ HIV to know their status, 95% of those diagnosed to receive ART, & 95% of those on ART to achieve viral suppresion - we need efforts to improve HIV testing, treatment access & adherence\n- \n- HIV pathogenesis & Immunological effects >>>\n    - CD4+ T cell depletion - HIV primarily infects CD4+ T lymphocytes, leading to their progressive depletion â‡’ impairing immune system's ability to fight off disease & infections\n    - opportunistic infections - individuals w/ advanced HIV infection (AIDS) are susceptible to wide range of opportunistic infections (Kaposi's sarcoma, Tuberculosis) - type of infection that occurs depending on level of immunosuppression\n    - HIV disrupts immune system balance & immune activation\n    - HIV infection is associated w/ shift towards TH2-dominant immune response - leading to increased susceptibility to allergies & other autoimmune disorders\n    - CCR5 & CXCR4 coreceptors are required for HIV entry into host cells - individuals w/ deletion in the CCR5 gene are resistant to HIV infection\n    - Elite controllers - a small percentage of individuals w/ HIV infection are able to control viral replication w/out antiretroviral therapy - studying these subjects \n- \n- Clinical manifestations of HIV infection >>>\n    - Acute HIV infection\n        - 1-3 weeks after infection\n        - mono-like symptoms (fever, rash, swollen lymph nodes, fatigue)\n        - may be asymptomatic\n        - is often missed bc symptoms are non-specific\n    - asymptomatic phase\n        - can last many years, w/ few or no symptoms\n        - viral replication continues & immune system is gradually depleted\n    - AIDS-defining illnesses \n        - opportunistic infections & cancers that occur when CD4+ cell counts fall below 200 cells/mm3 (normal 500-1,500/mm3)\n    - AIDS-related complex (ARC)\n        - a stage of HIV characterized by persistent generalized lymphadenopathy, fever, chronic diarrhea, weight loss \n        - ARC represents the transition phase between asymptomatic infection and AIDS\n- opportunistic infection examples >>>\n    - Kaposi's sarcoma\n    - tuberculosis\n    - candidiasis\n    - CMV infection\n    - cryptococcal meningitis\n    - CNS toxoplasmosis\n    - molluscum contagiosum\n    - multi-dermatomal herpes zoster (crossing midline)\n    - the spectrum of infections depends on level of immunosuppression \n- \n- HIV diagnosis >>>\n    - serological tests - enzyme-linked immunosorbent assay (ELISA) to detect Ab against HIV\n    - 4th gen tests detect both antibodies & p24 Ag, allowing earlier diagnosis ~4-6 weeks\n- treatment >>>\n    - viral load testing\n        - measures HIV RNA in blood - indicating viral replication levels\n        - crucial for assessing treatment response & treatment decisions\n    - CD4+ T cell count\n        - measure CD4+ cells in blood, determining status of immune system\n        - used to stage HIV infection & monitor disease progression\n    - ART - AntiRetroviral Therapy\n        - combination of drugs that suppress viral replication & improve immune function \n        - highly effective\n- classes of ART drugs >>>\n    - Nucleoside reverse transcriptase inhibitors (NRTIs)\n    - non-nucleoside reverse transcriptase inhibitors (NNRTIs)\n    - protease inhibitors\n    - integrase inhibitors \n    - entry inhibitors (fusion inhibitors & CCR5 antagonists)\n    - drug resistance\n        - HIV can develop resistance to antiretroviral drugs\n        - major challenge in HIV treatment, requiring careful monitoring & regimen adjustments\n- Treatment goals >>>\n    - viral suppression - undetactable viral load\n    - improved immune function - â†‘ CD4+ cell count\n    - improved quality of life\n    - prevention of opportunistic infections & AIDS-related complications\n    - treatment goals are individualized and based on patient's clinical status & other factors\n- \n- HIV prevention strategies >>>\n    - safe sex practices (consistent & correct condom use, limiting number of sexual partners, avoid high-risk sexual behaviors)\n    - needle exchange programs\n    - STI testing & treatment\n    - mother-to-child prevention strategies\n    - a combo of strategies is most effective\n    - Pre-exposure prophylaxis (PrEP)\n        - daily oral medication (tenofovir/emtricitabine) that reduces risk of HIV infection in high-risk individuals - needs to be taken consistently\n    - Post-exposure prophylaxis (PEP)\n        - antiretroviral medication taken after potential exposure to HIV to prevent infection\n        - must be started within 72h after exposure to be effective", "task_type": "study_guide_generation", "subject": "infectious_diseases", "topic": "hiv"}
{"instruction": "Create a comprehensive study guide for Brain Abscess optimized for medical exam preparation.", "input": "Topic: Brain Abscess", "output": "- what is it? >>>\n    - a localized collection of pus within the brain parenchyma\n    - typically begins as cerebritis (focal brain inflammation), which encapsulates within 5 days, forming a mass\n    - early diagnosis - crucial for reduced mortality\n- etiology >>>\n    - the origin & causative organisms can vary a lot\n    - otogenic\n        - most common in past, now less\n        - often by Streptococcus species (both aerobic & anaerobic) - bacteria are common oral flora\n        - spreading from otitis media & mastoiditis\n    - post-traumatic/post-operative\n        - increasingly common due to surgical procedures\n    - hematogenous - spread via bloodstream\n        - common in immunocompromised (cancer pat. under chemo, transplant recipients)\n        - Gram- bacteremia is important RF in neutropenic patients\n    - other\n        - Toxoplasma gondii - most common cause in HIV patients\n        - Listeria monocytogenes\n        - Tuberculosis - leading cause in low-income countries\n- \n- Localization & symptoms >>>\n    - the abscess location provides clues to its origin\n    - frontal lobes â€’ often from sinusitis\n    - temporal lobes/cerebellum â€’ often from otitis media\n    - multiple sites â€’ suggest hematogenous spread, require investigation of primary source\n    - symptoms â€’ highly variable but commonly include:\n        - headache\n        - AMS - Altered Mental Status\n        - fever\n        - <50% of cases present all 3\n        - neurological symptoms depend on mass size, location, edema\n- \n- Diagnosis >>>\n    - Imaging\n        - CT scans reveal round lesion with hypodense center (pus) & surrounding edema\n        - MRI provides better visualization of abscess & surrounding edema\n        - MRI is superior to CT in detecting early abscesses & assessing extent of edema\n    - other\n        - lumbar puncture, avoided due to risk of herniation\n            - if performed, show â†‘ WBC & protein levels\n        - blood culture might identify causative organism, but often negative\n        - surgical aspiration or biopsy, often necessary for definitive diagnosis\n- management >>>\n    - antibiotics\n        - empiric broad-spectrum antibiotics initiated on suspected source & patient RF\n        - selection refined once causative organism is identified \n        - treatment 4-6 weeks\n    - corticosteroids\n        - to reduce cerebral edema\n    - surgical intervention\n        - neurosurgical consultation recommended for all brain abscesses\n        - surgical excision or aspiration (needle drainage)\n        - choice depends on abscess size, location & response to medication\n- \n- \n- \n- Infection vs Colonization >>>\n    - infection\n        - presence of microorganism **with** alteration of organ/tissue structure or function\n        - clinical symptoms are present\n    - colonization\n        - presence of microorganism **without** alteration of organ/tissue structure or function\n        - no clinical symptoms\n- anitmicrobial stewardship >>>\n    - the responsible use of antimicrobials to prevent development & spread of antibiotic resistance\n    - so to decrease the spread of drug-resistant organisms\n- Microbiota interactions >>>\n    - interactions between host's microbiota & pathogens influences disease development\n    - lactobacilli VS candida â€’ reduction in lactobacilli can lead to candidiasis\n    - clostridioides difficile â€’ antibiotic-induced dysbiosis can lead to C.difficile infection - potentially causing megacolon & death\n- \n- Infectious Disease - transmission routes >>>\n    - airborne â€’ droplets (influenza, meningitis, tuberculosis)\n    - contact â€’ direct contact with lesion or surfaces (erysipelas, varicella)\n    - fecal-oral â€’ ingestion of contaminated food/water (HAV, Salmonella)\n    - Sexual â€’ sexual contact (STIs)\n    - Vector-borne â€’ through arthropods (mosquitoes, ticks, fleas)\n- \n- Fever of Unknown Origin (FUO) >>>\n    - defined as fever>38.3ÂºC for at least 3 weeks w/out a diagnosis after 3 days of investigation\n    - diagnostic approach â€’ systemic approach ideally:\n        - detailed history: travel, occupation, hobbies, animal contact, sexual history, drugs\n        - physical examination\n        - laboratory investigations: CBC, inflammatory markers, blood culture, imaging (chest X-ray, CT, MRI)\n        - metagenomics & next-gen sequencing â€’ used to identify unusual or unknown pathogens\n- \n- Infection Disease consultation â€’ questions >>>\n    - travel history (recent travel to endemic areas)\n    - vaccination status\n    - occupational/hobby exposure\n    - animal contact (wild or domestic)\n    - contact w/ others w/ similar symptoms \n    - dietary history (potentially foodborne)\n    - Immunodeficiency \n    - previous infections (history of recurrent or unusual infections)\n    - use of devices/prostheses\n    - antibiotic allergies\n- infection disease consultation - considerations >>>\n    - epidemiology - understanding local prevalence of infections\n    - common vs uncommmon pathogens - consider both \n    - source control - addressing primary source of infection is crucial\n    - iatrogenic causes - some medication (incl. antibiotics) can cause fever\n- \n- Antibiotic Resistance >>>\n    - major global health threat\n    - overuse of antibiotics contributes to selection & spread of resistant bacteria\n    - MDR pathogens are increasingly common â€’ leading to treatment failures & increased mortality\n-", "task_type": "study_guide_generation", "subject": "infectious_diseases", "topic": "brain_abscess"}
{"instruction": "Create a comprehensive study guide for Fungal Infections optimized for medical exam preparation.", "input": "Topic: Fungal Infections", "output": "- fungi >>>\n    - eukaryotic, heterotrophic microorganisms\n    - digest food externally using hydrolytic enzymes - explains ability to invade blood vessels, often causing hemorrhage \n    - primarily aerobic\n    - synthesize lysine\n    - plasma membranes contain ergosterol\n    - reproductive units: conidia (asexual) & spores (can have asexual or sexual origin)\n- yeasts VS molds >>>\n    - yeasts â€’ single-celled fungi reproducing by budding\n    - molds â€’ multicellular fungi forming hyphae (filaments)\n    - dimorphic fungi â€’ exhibit both yeast & mold forms, depending on environmental conditions (T, CO2, pH) - grow as yeast or spherules in vivo or at 37ÂºC in vitro, and as molds at 25ÂºC\n    - classification based on morphology is crucial for identification & understanding the potential severity of infection\n- \n- classification of fungal infections, based on >>>\n    - site of infection:\n        - superficial\n        - cutaneous\n        - subcutaneous\n        - systemic\n    - route of acquisition:\n        - exogenous (airborne, cutaneous, percutaneous)\n        - endogenous (from normal flora (e.g. candida in GI) - particularly common in immunocompromised\n    - virulence:\n        - primary pathogens infect healthy individuals\n        - opportunistic pathogens infect immunocompromised hosts\n- \n- \n- diagnosis of fungal infections - depend on: >>>\n    - clinical presentation:\n        - symptoms vary depending on fungus & site of infection\n        - thorough history, traveling history & underlying medical conditions - taken into consideration\n    - miroscopic examination:\n        - examination of specimens - tissue biopsies - to identify fungal elements (hyphae, yeast)\n        - gram staining for initial assessment\n    - culture:\n        - the GOLD STANDARD\n        - on selective media\n        - for definitive diagnosis - but can be time-consuming\n    - serological tests:\n        - detection of fungal Ag & Ab in serum\n        - for rapid diagnosis, but limitation in sensitivity & specificity\n    - molecular diagnostics:\n        - PCR-based methods for rapid & sensitive fungal DNA detection\n- \n- \n- Antifungal Treatment >>>\n    - treatment choices depend on fungus, site of infection & host factors\n    - Major classes:\n        - Azoles: inhibit ergosterol synthesis (e.g. fluconazole)\n        - echinocandins: inhibit cell wall synthesis\n        - polyenes: bind to ergosterol, disrupting membrane integrity (e.g. amphotericin B)\n    - Drug resistance:\n        - Candida auris & azole-resistant Aspergillus fumigatus - significant concerns due to resistance to commonly used antifungals\n- \n- specific fungal infections >>>\n    - Candida Infections\n    - Aspergillus Infections\n    - murcomycosis (zygomycosis)\n    - Histoplasmosi\n- \n- \n- Candida Infections >>>\n    - candidemia - requires prompt treatment with echinocandins or amphotericin B\n        - source control is crucial\n    - invasive candidiasis - can affect multiple organs (kidney, liver, lungs, CNS)\n        - RF: neutropenia, broad-spectrum antibiotic use, indwelling devices\n    - mucocutaneous candidiasis â€’ oral thrush, esophagitis, vulvovaginitis\n- \n- Aspergillus Infections >>>\n    - Invasive Aspergillosis\n        - severe infection - esp. in immunocompromised\n        - RF: neutropenia, corticosteroids & hematopoietic stem cell transplant\n        - treatment: azoles, often combined with echinocandins\n    - Allergic Bronchopulmonary Aspergillosis (ABPA)\n        - Hypersensitivity reaction in patients with asthma\n        - characterized by elevated IgE levels, eosinophilia\n- \n- Mucormycosis (zygomycosis) >>>\n    - caused by Mucorales\n    - characterized by ribbon-like hyphae with septations\n    - RF: diabetes mellitus (ketoacidosis), glucocorticoid use, hematologic malignancies\n    - often presents with rhino-orbital-cerebral involvement - requiring surgical debridement & antifungal therapy (amphotericin B, azoles)\n        - so involves sinuses, eyes, & brain\n- \n- Histoplasmosis >>>\n    - caused by Histoplasma capsulatum - found in soil contaminated w/ bird or bat droppings\n    - most infections are asymptomatic or mild - severe disease can involve lungs or disseminate to other organs\n    - treatment depends on severity â€’ may involve azoles, or amphotericin B\n- \n-", "task_type": "study_guide_generation", "subject": "infectious_diseases", "topic": "fungal_infections"}
{"instruction": "Create a comprehensive study guide for Infective Endocarditis optimized for medical exam preparation.", "input": "Topic: Infective Endocarditis", "output": "- Epidemiology >>>\n    - subjects with prosthetic devices in heart\n    - elderly at risk\n- \n- Etiology >>>\n    - S.aureus - main one \n    - B.streptococci\n    - Candida\n- \n- Pathology >>>\n    - most commonly occurs due to Sepsis and/or Systemic Embolization\n    - presence of bacteria and/or fungi in bloodstream\n    - bacteria attach to damaged valve surfaces, forming nonbacterial thrombotic vegetations, due to turbulence\n    - bacteria proliferate within vegetation, protected from immune response\n- \n- \n- clinical manifestations - symptoms >>>\n    - acute form:\n        - rapid onset of fever\n        - chills\n        - shortness of breath, chest pain\n        - all occur after 1-2 weeks of bacteremia\n        - commonly associated with S.aureus\n    - subacute form:\n        - milder symptoms, like low-grade fever\n        - fatigue\n        - weight loss\n        - arthralgia\n        - linked to less aggressive Coag- staphylococci\n- \n- Clinical signs >>>\n    - embolic phenomena\n        - petechiae\n        - Osler nodes - painful lesions on fingers/toes\n        - Janeway lesions - painless macules on palms/soles\n        - Roth spots - retinal emboli\n    - Heart murmurs\n        - new or worsening murmurs due to valvular dysfunction\n- \n- transmission >>>\n    - intravenous catheters or drug injections \n    - dental procedures or surgical interventions\n    - individuals with pre-existing heart conditions, prosthetic valves, & IV drug users\n    - so bacteria enter bloodstream through these routes\n- \n- diagnosis >>>\n    - clinical suspicion - based on symptoms, RF, physical examination\n    - Blood cultures - must show bacterial presence\n    - Imaging; echocardiography, essential for identifying cardiac lesions\n    - criteria: 2 positive blood cultures + positive echocardiography\n- \n- Treatment >>>\n    - IV systemic HIGH dose Bactericidal antibiotics for 4 weeks & 6-8 weeks for patients w/ prosthetic valves\n    - cardiac surgery - for severe cases w/ significant valvular dmg, uncontrolled infection, or large vegetations\n- \n- complications >>>\n    - risk for metastatic spread - secondary infections in kidneys, brain\n    - local spread â‡’ valvular dmg, pericarditis\n    - embolic complications - can lead to stroke, MI, organ dmg\n-", "task_type": "study_guide_generation", "subject": "infectious_diseases", "topic": "infective_endocarditis"}
{"instruction": "Create a comprehensive study guide for Sexually Transmitted Diseases (STDs) optimized for medical exam preparation.", "input": "Topic: Sexually Transmitted Diseases (STDs)", "output": "- epidemiology >>>\n    - estimated hundred of millions of new STI infections annualy\n    - Chlamydia, gonorrhea, syphilis, trichomoniasis - the most common ones - esp. in low income countries\n    - trends - increasing rates of antibiotic resistance - esp. for gonorrhea & chlamydia\n    - concerning rise in syphilis infections, esp. in MSM\n    - Risk factors: Multiple sex partners, unprotected sex, inconsistent condom use, STI history, substance abuse\n- classification of STDs >>>\n    - curable STDs - infections that can be treated & eliminated w/ appropriate antibiotics or other medication\n        - chlamydia, gonorrhea, syphilis & trichomoniasis\n        - cure depends on specific pathogen, antibiotic susceptibility, patient adherence to medication\n    - incurable STDs - infections that cannot be cured, but can be managed w/ medication to reduce symptoms & prevent transmission\n        - HIV, HSV, HPV\n        - management focuses on suppresing viral replication, managing symptoms & preventing complications (QWER-viral latency & pathogenesis course, challenges developing effective antiviral therapies)\n    - also classification based on pathogen type:\n        - bacterial STDs - caused by bacteria & are typicaly treatable w/ antibiotics - e.g. syphilis, chlamydia, gonorrhea - antibiotic resistance is a growing concert\n        - viral STDs - caused by viruses & are generally incurable, but manageable w/ antiviral medications - e.g. HIV, HSV, HPV \n        - other STDs - fungi (candida), protozoa (trichomonas vaginalis), ectoparasites (lice, scabies) - treatment depends on specific pathogen\n- Bacterial pathogens causing STDs:\n    - Chlamydia trachomatis >>>\n        - obligate intracellular bacterium\n        - cause urethritis, cervicitis, PID & LGV\n    - Neisseria gonorrhea >>>\n        - Gram- diplococcus\n        - cause urethritis, cervicitis, proctitis & disseminated gonococcal infection\n    - Treponema pallidum >>>\n        - spirochetes causing syphilis\n        - has primary, secondary, tertiary stages\n            - 1Âº primary lesion at site of infection, goes away on its own\n            - 2Âº spreads to lymph & blood vessels & cause systemic rash - infectious\n            - latent - dormant stage for up to many years - after it we get either recurrent 2Âº or if immunosuppresed or untreated, we get 3Âº\n            - 3Âº - most severe, cause CNS & circulatory problems, neurosyphilis, gumma (granuloma formation) \n    - Haemophilus Ducreyi >>>\n        - gram- bacullus\n        - cause chancroid - a painful genital ulcer\n        - can also cause inguinal lymphadenopathy\n- Viruses causing STDs:\n    - Human Papillomavirus (HPV) >>>\n        - cause genital warts\n        - linked to cervical, anal & other cancers\n        - many strains exist, some high-risk, & some lower-risk\n    - Herpes Simplex Virus (HSV) >>>\n        - cause genital herpes\n        - characterized by painful blisters & sores\n        - HSV-2 primarilly associated w/ genital herpes, while HSV1, with oral herpes\n    - Human Immunodeficiency Virus (HIV) >>>\n        - causes Acquired Immunodeficiency Syndrome (AIDS) - leading to severely compromised immune system\n- Protozoa causing STDs >>>\n    - trichomonas vaginalis - causing trichomoniasis - affecting vagina & urethra\n- Fungi causing STDs >>>\n    - candida - causing candidiasis - a yeast infection affecting vagina, penis & other areas\n- Ectoparasites causing STDs >>>\n    - pediculus humans pubis (pubic lice)\n    - Sarcoptes scabiei (scabies)\n    - not strictly STIs but can also me transmitted sexually\n- Clinical manifestations of STDs >>>\n    - genital ulcers - painful ulcers charateristic of chancroid (Haemophilus Ducreyi) & herpes genitalis (HSV) \n        - **non-painful ulcers are characteristic of syphilis!!!** \n    - urethritis/cervicitis/proctitis - symptoms: discharge, pain during urination, bleeding - associated w/ chlamydia & gonorrhea\n    - genital warts (condyloma acuminata) - by HPV - small flat OR large cauliflower-shaped warts - on genitals, anus & surrounding areas\n    - Pelvic Inflammatary Disease - chlamydia & gonorrhea - affecting fallopian tubes & ovaries - abdominal pain, fever, abnormal vaginal discharge\n    - others:\n        - vaginal discharge, itching, pain during urination - trichomoniasis\n        - vaginal or penile itching, burning & discharge - candidiasis\n        - scabies - intense itching & rash\n- Diagnosis & Treatment of STDs \n    - Diagnostic tests >>>\n        - depend on suspected infection:\n        - microscopy, culture, PCR, serology (detect Ab against pathogen in blood)\n    - Treatment >>>\n        - depends on pathogen\n        - antibiotics used for bacteria, & antivirals for viruses\n    - Diagnosis & Treatment - Chlamydia >>>\n        - Chlamydia trachomatis - PCR / culture\n        - azithromycin, doxycycline\n    - Diagnosis & Treatment - gonorrhea >>>\n        - Neisseria gonorrhea - culture / PCR\n        - ceftriaxone, azithromycin (often combined)\n    - Diagnosis & Treatment - syphilis >>>\n        - Treponema pallidum - serology / dark-field microscopy (bc tiny!)\n        - Benzanthine penicillin\n    - Diagnosis & Treatment - Trichomoniasis >>>\n        - Trichomonas vaginalis - microscopy / PCR\n        - metronidazole\n    - Diagnosis & Treatment - genital herpes >>>\n        - Herpes simplex virus - PCR, viral culture, serology\n        - acyclovir, valacyclovir\n    - Diagnosis & Treatment - genital warts >>>\n        - HPV - visual inspection, colposcopy\n        - topical treatments / LEEP / surgical removal\n    - scabies >>>\n        - dermatoscope - itchy all over body (mostly knees & palms), increased at night \n        - transmission through prolonged contact - ectoparasite\n        - permethrin cream - leave overnight, then repeat after 1 week - also quarantine clothes etc.\n        - ivermectin pill - once & then once again after 1 week - contraindication for pregnant women & <15kg kids\n        - also crusted scabies - in immunosuppresed individuals - thousands of mites on individual, compared to ~10 in classic scabies\n    - lice >>>\n        - pubic lice - on pubic hair and armptis\n        - can carry other diseases - Epidemic Typhus - caused â†‘ mortality before antibiotics - classified as category B-bioterrorism agent!\n- Prevention of STDs >>>\n    - the most effective is abstinence - the only reliable\n    - practicing safe sex - condoms (correctly & consistently) + monogamy\n    - partner notification - inform past sexual partners about STI diagnosis\n    - vaccination - available for HPV - can prevent certain types of cervical, anal cancers\n    - regular screening - to detect early, & even asymptomatic - also PrEP & PEP for HIV\n- \n-", "task_type": "study_guide_generation", "subject": "infectious_diseases", "topic": "sexually_transmitted_diseases"}
{"instruction": "Create a comprehensive study guide for Non-Tuberculous Mycobacteria (NTM) optimized for medical exam preparation.", "input": "Topic: Non-Tuberculous Mycobacteria (NTM)", "output": "- \n- what are they? >>>\n    - a large group of mycobacteria that are distinct from M.tuberculosis complex (M.tuberculosis, M.bovis, M.africanum, etc.)\n    - there are over 150 species, about 60 considered potentially pathogenic to humans\n- classification by growth rate >>>\n    - Rapid growers (RGM): colony formation <7 days - M.abscessus particularly associated with CF patients\n    - Slow Growers: colony formation 7-40 days - e.g. M.avium complex, M.xenopi\n    - Intermediate Growers: conoly formation 7-10 days - e.g. M.marinum, M.gordonae\n- classification by pathogenicity >>>\n    - considering likelihood of causing disease in immunocompetent vs immunocompromised hosts\n    - some are rarely pathogenic, even in immunocompromised individuals, while others are opportunistic pathogens requiring significant immune suppresion to cause disease\n- Epidemiology >>>\n    - found in various environments - e.g. soil, water, dust - its widespread distribution contributes to potential human infections\n- transmission routes >>>\n    - inhalation - most common, primarily through aerosolized particles from contaminated water\n    - ingestion - contaminated food/water\n    - direct contact - cutaneous inoculation through wound or skin lesions\n    - M.abscessus potentially limited person-to-person transmission - esp. in CF patients\n- risk factors >>>\n    - Immunosuppresion (HIV, under immunosuppressive medication, other immunodeficiencies)\n    - underlying lung disease (CF, COPD, bronchiectasis, create favorable environment for NTM colonization)\n    - others (age, genetic predispositions (CFTR gene), etc.\n- NTM & amoebas >>>\n    - some NTM species can survive & replicate within free-living amoebas\n    - providing protection from environment & contribute to â†‘ antibiotic resistance\n    - amoebas in water, pose significant risk to immunocompromised individuals \n- Clinical Presentation of NTM infections >>>\n    - Pulmonary Disease\n        - the most common manifestation\n        - often presenting as chronic bronchopulmonary disease\n        - symptoms non-specific ~ chronic (productive) cough, fatigue, weight loss, sometimes hemoptysis\n        - radiological findings: nodules, cavities, bronchiectasis \n        - frequent cause: M.avium complex (M.avium, M.chimaera)\n    - Extrapulmonary Disease\n        - NTMs can infect extrapulmonary sites, although most frequently lungs\n        - Lymphadenitis: painless cold lymph nodes - mostly affecting children\n        - Disseminated Disease: most common in severely immunocompromised individuals\n        - Skin & Soft Tissue Infections: caused by RGM, following skin lesion\n        - Bone & Joint Infections: following trauma or surgery\n        - Catheter-related Infections: RGM associated w/ Central Venous Catheter (CVC) & peritoneal catheter infections\n- NTM diagnosis >>>\n    - microbiological diagnosis:\n        - isolation of the same NTM species from at least 2 separate sputum samples or from a bronchoalveolar lavage sample (BAL)\n        - PCR increasingly being used, but may not be as specific as culture\n    - Radiological diagnosis:\n        - chest-xrays & High resolution tomography (HRCT)\n        - findings may include nodules, cavities, bronchiectasis \n- NTM infections treatment >>>\n    - often long - 12-24 months\n    - requires multiple antibiotics, and may have significant side effects\n    - the choice of antibiotics depends on specific NTM species & its susceptibility profile\n    - macrolides (azithromycin, clarithromycin), ethambutol, rifampin or rifabutin are usually used in combination\n    - for M.abscessus, treatment is challenging & may involve IV therapy, followed by prolonged oral regimens\n    - NTM infections are generally difficult to treat bc of antibiotic resistance, slow growth rates, biofilm formation\n    - inhaled Liposomal Amikacin - new antibiotic option under development, reduced toxicity, used for multiple drug resistant strains\n- \n-", "task_type": "study_guide_generation", "subject": "infectious_diseases", "topic": "non_tuberculous_mycobacteria"}
{"instruction": "Create a comprehensive study guide for Tropical Diseases optimized for medical exam preparation.", "input": "Topic: Tropical Diseases", "output": "- Malaria\n    - ## Malaria\n        - **epidemiology** >>>\n            - Endemic in: subsaharan Africa, Asia, South America\n            - Transmission by Anopheles mosquitoes\n            - High-risk populations: children, pregnant women\n        - **Pathophysiology**: >>>\n            - Caused by  *Plasmodium*  species - primarily  *Plasmodium falciparum, but also P.ovale, P.malariae, P.vivax*  \n            - Vector: Anopheles mosquitos ( and a human host)\n            - Resistant Host if: Sickle cell anemia, G6PD def., thalassemia, newborns up to 6 months\n            - incubation 7-30 days (even more in plasmodium malariae)\n            - The lifecycle begins with the mosquito injecting sporozoites into the bloodstream â‡’ which migrate to the liver (can stay there for years) â‡’ multiply â‡’ and then infect RBCs â‡’ leading to their destruction\n        - **Clinical Manifestations:** >>>\n            - onset up to months after infection!\n            - Symptoms include: fever, chills, sweating, headache, nausea, and vomiting\n            - Severe cases can lead to **cerebral malaria**, **severe anemia**, and **acute respiratory distress syndrome, Blackwater fever** \n            - Signs include **splenomegaly** and **hepatomegaly** \n        - **cerebral malaria** >>>\n            - altered state of consciousness up to coma\n            - â†‘ mortality\n            - neurological sequelae\n        - **Blackwater fever** >>>\n            - sudden high fever onset\n            - Intravascular hemolysis\n            - lumbar pain\n            - jaundice \n            - dark urine / hemoglobinuria\n        - **complicated vs uncomplicated malaria** >>>\n            - Uncomplicated malaria: mild symptoms, no organ dysfunction, treatable with oral medications\n            - Complicated malaria: severe symptoms, potential organ failure, requires intravenous treatment\n            - Symptoms of uncomplicated: fever, chills, headache, sweating\n            - Symptoms of complicated: severe anemia, respiratory distress, cerebral malaria\n            - Diagnosis: blood smear, rapid diagnostic tests for both types\n        - Transmission >>>\n            - Through the bite of infected Anopheles mosquitoes - primarily active during dusk and dawn\n        - **Diagnosis**: >>>\n            - Thick and thin blood smears to identify the parasite\n                - Thick: quantitative assesment, thick smear not much spread\n                - Thin: to accurately differentiate between species\n            - PCR\n            - Fluorescent dye\n            - rapid diagnostic tests (RDTs) are also available\n        - Treatment >>>\n            - First-line treatment includes Artemisinin-based Combination Therapy (ACT) for non-severe malaria - oral, IV, or rectal\n            - Severe cases require IV \n            - Experimental vaccine\n            - Ivermectin - antiparasitic drug\n            - supportive care; antibiotics, glucose, ventilation, fluid balance\n    - \n    - \n- Dengue Virus\n    - Epidemiology >>>\n        - â†“ mortality, â†‘ incidence\n        - South America, Tropical countries, Asia\n        - Co-infection w/ **malaria** \n    - pathology >>>\n        - general leukopenia/thrombocytopenia\n        - Classic Dengue (minority)\n            - fever, headache, arthromyalgia, lymphadenitis, rash\n        - Dengue Hemorrhagic fever (majority)\n            - fever, hemorrhages, thrombocytopenia, vomit\n            - â†‘ mortality in untreated\n        - Dengue Shock Syndrome\n            - â†“ BP\n            - â†‘ vasc. permeability â‡’ hypovolemia\n            - signs of shock; bleeding, fever\n    - Diagnosis >>>\n        - IgM (5gg), IgG (7gg), RNA first days\n        - Tourniquet test - marker for capillary fragility (BP cuff, block circulation for minutes, release some pressure, check for petechiae)\n    - treatment >>>\n        - treat fever & shock â‡’ hydration, pain management\n        - NO aspirin / NSAIDs â‡’ can exacerbate bleeding, also GI bleeding\n    - \n- Zika Virus\n    - epidemiology >>>\n        - related to dengue/yellow fever/West Nile Virus\n        - Transmission through Aedes mosquitoes\n        - Geographic distribution: Americas, Africa, Asia\n        - RF: travel\n        - Potential for asymptomatic cases\n    - Pathology >>>\n        - flaviviridae - 4-14gg incubation\n        - transmission through urban & selvatic (jungle) cycle\n        - transmission: placenta, blood, sexual, lab\n    - symptoms >>>\n        - 80% asymptomatic \n        - mild illness but lasts long time - exanthema, pruritus\n        - rare mortality\n        - complications for fetus; microencephaly\n    - diagnosis >>>\n        - viral RNA detection (saliva, urine, CSF, amniotic fluid)\n        - Zika Ab\n        - on born baby: histological exam of placenta, cord serum, frozen placenta tissue test\n    - treatment >>>\n        - No antiviral therapy\n        - supportive treatment\n        - No aspirin/NSAIDs, before ruling out dengue\n- Chikungunya\n    - Transmission >>>\n        - Aedes mosquitos - like Dengue, Zika, Chikungunya, Yellow fever Virus\n        - 4-7gg incubation\n    - symptoms >>>\n        - **acute phase** \n            - up to 10gg\n            - arthritis, rash\n        - **post acute phase**\n            - 4-12 weeks\n            - arthritis slowly fades - chronic asthenia/pain\n        - **chronic phase**\n            - >12 weeks\n            - chronic long lasting joint pain\n    - treatment >>>\n        - general supportive care - pain medication (e.g. codeine, acetaminophen)\n- yellow fever\n    - epidemiology >>>\n        - tropical countries, â†‘ incidence\n        - transmitted by aedes mosquitos\n    - pathology >>>\n        - flaviviridae - yellow fever virus\n        - 3-6gg incubation\n        - cause hepatic dmg + hemorrhagic symptoms\n    - symptoms >>>\n        - fever, chills, myalgia, nausea/vomiting\n        - after defervescence â‡’ fever reappears, w/ jaundice, abd. pain, vomit â‡’ may lead to renal failure, pancreatitis, CNS invasion\n    - diagnosis >>>\n        - serology + PCR\n    - treatment >>>\n        - no specific treatment\n        - Vaccine - live attenuated - life-long protection\n    - \n- enteric fever\n    - > **ðŸ¤– Use AI to Create Cards from Notes\n\n**1. Paste or type notes\n2. Select text with your mouse\n3. Press â€œCreate AI Cardsâ€\n    - \n    - epidemiology >>>\n        - â†“ incidence\n        - contaminated food/water\n    - pathology >>>\n        - salmonella Typhi\n        - cause enteric fever/typhoid fever\n        - bacterial infection affecting intestine\n        - oro-fecal transm.\n        - chronic carriers in gallbladder/intestine (only human reservoir)\n        - last 4 weeks\n    - symptoms >>>\n        - fever, headache\n        - abd. pain, constipation / or diarrhea\n        - bradycardia\n        - rose spots - pink papules on abdomen, nipple, umbilical area\n    - diagnosis >>>\n        - hemoculture, stool\n    - Treatment >>>\n        - 3rd gen cephalosporins (e.g. ceftriaxone)\n    - \n- Chagas disease\n    - epidemiology >>>\n        - South america\n        - Trypanosoma Cruzi\n    - transmission >>>\n        - kissing bugs\n        - transplant\n        - contaminated food\n        - lab exposure\n        - vertically (all 3 routes)\n        - blood transfusion\n    - symptoms >>>\n        - acute trypanosomiasis\n            - mild disease, fever\n        - chronic infections\n            - cardiomyopathy: arrhythmias\n            - GI dysfunction: megacolon, megaesophagus\n    - diagnosis >>>\n        - serology & PCR\n    - treatment >>>\n        - nifurtimox + benznidazole (parasitic) - **ONLY for Chagas** \n- Helminths\n    - Pathology >>>\n        - soil helminths (tape worms, etc.) \n        - cause intestinal inf. w/ chronic anemia & neurodevelopment alterations\n        - in kids: assess malnutrition, deworming of kids\n    - symptoms >>>\n        - hypereosinophilia\n        - muscle pain\n        - fever\n        - GI symptoms\n        - can also be **asymptomatic** \n    - diagnosis >>>\n        - 3 stool samples â‡’ serology \n- shistosomiasis\n    - epidemiology >>>\n        - africa, South East Asia, South America\n        - RF: swimming\n        - Schistosoma - many species\n    - symptoms >>>\n        - intestinal shistosomiasis â‡’ granuloma\n        - Hepatosplenic shistosomiasis â‡’ portal hypertension\n        - urinary shistosomiasis â‡’ hematuria, chronic inf.\n        - **Katamaya **fever â‡’ â†‘ acute fever, cough, hypereosinophilia, lymphadenopathy\n    - diagnosis >>>\n        - urine or stool â‡’ check for eggs\n    - treatment >>>\n        - prophylaxis: avoid swimming in contaminated lakes\n        - multiple drug administration\n- Leishmaniasis\n    - epidemiology >>>\n        - many countries - incl. Italy\n        - sandfly vector \n        - transmission: vertical, vector, transplant\n    - pathology >>>\n        - by Leishmania parasites â‡’ infect. macrophages\n    - symptoms >>>\n        - cutaneous leishmaniosis â‡’ skin lesions\n        - Visceral leishmaniosis â‡’ kala-azar â‡’ intermittent fever, weight loss, splenomegaly\n    - diagnosis >>>\n        - cutaneous - biopsy of mucosa, PCR, culture\n        - visceral - liver, spleen, lymphnodes, bone marrow biopsy, serology, PCR\n    - treatment >>>\n        - Liposomal amphotericin B - (antifungal â†“ toxicity, â†‘efficacy - IV admin.", "task_type": "study_guide_generation", "subject": "infectious_diseases", "topic": "tropical_diseases"}
{"instruction": "Create a comprehensive study guide for Osteomyelitis optimized for medical exam preparation.", "input": "Topic: Osteomyelitis", "output": "- what is it >>>\n    - an infection of the bone\n    - can range from localized to a severe systemic illness\n- acute osteomyelitis >>>\n    - infection lasting days to weeks, with rapid onset of symptoms\n- chronic osteomyelitis >>>\n    - infection lasting months to years\n    - often involves recurrent episodes & formation of sequestra\n- sequestra >>>\n    - pieces of necrotic bone that separte from viable bone\n    - the hallmark of chronic osteomyelitis\n    - impede healing\n    - their presence often needs surgical removal\n- sinus tract >>>\n    - pathognomonic feature of osteomyelitis\n    - abnormal passage leading from a deep infection to the skin surface\n    - often drains pus\n- involucrum >>>\n    - new bone formation surrounding the area of infection\n    - basically the body's attempt to wall off infection\n- periosteal seeding >>>\n    - spread of infection from bone to periosteum \n    - can lead to further inflammation & bone destruction\n- cloacae >>>\n    - multiple draining passages that can form in chronic osteomyelitis\n    - often interconnected & can make treatment more challenging\n- bone ischemia >>>\n    - reduced blood flow to bone\n    - major factor in development of osteomyelitis - as it compromises ability to fight infection\n- \n- \n- classification of osteomyelitis >>>\n    - hematogenous & Non-hematogenous\n- \n- hematogenous osteomyelitis >>>\n    - bacteria reach bone via bloodstream\n    - more common in children & can affect multiple sites\n    - common pathogens: S.aureus, Beta-hemolytic streptococci, M.tuberculosis, Candida species\n- hematogenous osteomyelitis - RF >>>\n    - Diabetes mellitus\n    - Intravenous drug use\n    - Chronic kidney disease / hemodialysis\n    - Immunosuppression\n    - endocarditis\n    - Age (young children, elderly)\n    - vascular & orthopedic devices\n- \n- Non-hematogenous osteomyelitis >>>\n    - infection spreads directly to bone from adjacent tissues\n    - more common in adults \n    - often associated with trauma or surgery\n    - common pathogens: S.aureus, Coag-negative staphylococci, aerobic gram-negative bacilli, corynebacteria, fungi, mycobacteria\n- Non-hematogenous osteomyelitis - RF >>>\n    - poorly healing wounds (diabetic foot ulcers, decubitus ulcers)\n    - orthopedic hardware\n    - diabetes\n    - peripheral vascular disease\n    - peripheral neuropathy\n- \n- Diagnosis >>>\n    - culture ideally on bone biopsy sample - culture from other sources (swabs, sinus tracts) are prone to contamination & false-negative results\n    - blood cultures - may be positive in hematogenous osteomyelitis - but can be negative if bacteremia has resolved by time of diagnosis\n    - imaging\n- diagnosis - imaging >>>\n    - for acute (<2 weeks) â€’ CT or MRI for early detection\n    - for chronic (>2 weeks) â€’ MRI needed for complete assessment\n    - diabetic foot infections - MRI\n    - if there's metal hardware â‡’ nuclear imaging (e.g. bone scan)\n- Laboratory findings >>>\n    - â†‘ WBC \n    - â†‘ ESR - Erythrocyte Sedimentation Rate\n    - â†‘ CRP\n- \n- \n- Treatment >>>\n    - antibiotic therapy\n    - surgical debridement \n        - removal of infected bone & tissue\n        - essential for chronic osteomyelitis & cases w/ significant bone dmg or sequestra\n    - hardware removal\n        - might be necessary in cases of infection involving orthopedic implants\n    - non-hematogenous â‡’ often needs prolonged (6+weeks) IV or high bioavailability oral antibiotics, + surgical debridement\n    - hematogenous â‡’ less duration of antibiotic treatment (~4w) + generally w/out surgical debridement\n- \n- \n- specific forms of osteomyelitis >>>\n    - **vertebral osteomyelitis (spondylodiscitis)** \n        - infection of the vertebrae & intervertebral discs\n        - often presents w/ back pain - potentially leading to spinal deformities & neurological complications\n        - S.aureus is the most common pathogen\n    - **Sternoclavicular & Pelvic Osteomyelitis** \n        - more common in IV drug users - due to risk of bacteremia\n    - **Long bone Osteomyelitis ** \n        - more common in children\n- \n- \n- Diabetic foot infections & Osteomyelitis >>>\n    - a significant complication of diabetes (50% of diabetics) - foot ulcers â€’ often leading to osteomyelitis\n    - RF: neuropathy, peripheral vascular disease & Immunosuppression increase the risk (not only diabetes), previous foot ulcer (50% recurrence within 5y)\n        - neuropathy â€’ present in 80% of diabetic foot patients, leads to loss of sensation, pain, pressure - impaired microcirculation\n        - peripheral vascular disease â€’ reduced blood flow to feet - poor wound healing\n    - other RF: socioeconomic status, age, ethnicity, foot deformities\n    - treatment: precise debridement, wound care, pressure reduction & antibiotic therapy (tailored to severity of infection & presence of osteomyelitis)\n- \n- \n- prosthetic joint infections (PJI) >>>\n    - infection involving joint prosthesis, classified by onset of timing (early, delayed, late)\n    - RF: comorbidities, prior infections, prolonged surgery, S.aureus bacteremia!\n    - diagnosis: imaging, serum markers, synovial fluid analysis\n    - treatment: antibiotics - amputation if necessary, DAIR (debridement, antibiotics, implant retention)", "task_type": "study_guide_generation", "subject": "infectious_diseases", "topic": "osteomyelitis"}
{"instruction": "Create a comprehensive study guide for CNS Infections optimized for medical exam preparation.", "input": "Topic: CNS Infections", "output": "- intro\n    - CNS highly sensitive to infection >>>\n        - due to limited space & fragile structures\n        - so increase in volume (e.g. inflammation, mass) can cause rapid & severe complications\n    - cause of CNS infections >>>\n        - infectious agents (bacteria, fungi, viruses, protozoa, helminths) are the primary cause\n        - some non-infectious conditions mimic CNS infections - e.g. cancer, autoimmune disorders, medications\n    - clinical presentation >>>\n        - variable depending on causative agent, location, patient factors\n        - can ange from acute (hours to days), to subacute or chronic (weeks to months)\n        - common symptoms: fever, headache, altered mental status (AMS)\n        - possible seizures\n    - differential diagnosis >>>\n        - crucial bc potential for rapid deterioration\n        - requires consideration of infectious & non-infectious causes\n        - using: detailed history, neurological exam, laboratory tests \n    - Neuronal regeneration >>>\n        - limited to specific areas (hippocampus, neuro-olfactory mucosa) - all others dont regenerate\n    - gray vs white matter >>>\n        - pathologies affecting gray matter (cortex) often cause seizures\n        - white matter pathologies may present with neurological deficits & seizures\n    - CNS anatomical barriers >>>\n        - lack of defined anatomical barriers between bran, meninges & spinal cord allows rapid spread of infection\n        - BBB - endothelial cells, pericytes & astrocyte end-feet - protecting brain parenchyma from blood-borne pathogens & toxins\n        - Blood-CSF barrier - located in choroid plexus - less restrictive than BBB; viruses, drugs, toxins can cross more easily\n        - areas without tight junctions - postrema, hypothalamus, 3rd ventricle - so more susceptible to drugs & toxins \n    - \n    - \n    - Meninges & CSF\n        - meninges >>>\n            - 3 layers of protective membranes surrounding brain & spinal cord\n                - dura mater - outermost, tough fibrous, in contact w skull\n                - arachnoid mater - web-like, contains arachnoid villi for CSF reabsorption - most commonly involved in meningeal infections\n                - pia mater - delicate, directly adheres to brain & spinal cord - inflammation here directly affects neurotransmission\n        - CSF >>>\n            - clear, colorless fluid circulating around brain & spinal cord\n            - avg volume: 150mL\n            - produced by choroid plexus in each ventricle\n            - circulates through subarachnoid space & is reabsorbed via arachnoid villi - turned over 3-4x daily\n            - 2/3 iltrafiltrated plasma, 1/3 brain EC fluid\n            - contains proteins, glucose, lymphocytes\n            - changes in composition or pressure are significant indicators of disease\n    - \n    - Lumbar Puncture (LP) >>>\n        - sterile procedure to collect CSF for analysis\n        - performed between L3-L4 or L2-L3 to avoid spinal cord injury\n        - complications - headache most common, infection, local bleeding, brain herniation (most serious, potentially fatal)\n    - \n    - CSF analysis >>>\n        - routine:\n            - cell count - â†‘ WBCs indicate infection - â†‘ RBCs indicate hemorrhage\n            - glucose - â†“ suggests bacterial infection - bc they consume it\n            - protein - â†‘ indicates inflammation or BBB disruption\n            - gram stain - to identifiy bacteria\n            - culture - to identify & isolate bacteria or fungi\n        - additional more specific:\n            - india ink/cryptococcal antigen - for cryptococcal meningitis\n            - IgM / IgG - for certain viral infections\n            - cytology - to rule out malignancy\n        - Reibergram - measures albumin & IgG in CSF & serum to assess BBB integrity & intrathecal IgG synthesis\n        - Normal CSF - clear, colorless, <5 cells/mm3, glucose >50% of blood glucose, protein <59mg/dL\n- Meningitis\n    - ## bacterial Meningitis\n        - common causes: >>>\n            - S.pneumoniae\n            - N.meningitidis\n            - H.influenzae\n            - depends geographically\n        - RF >>>\n            - sinusitis\n            - otitis media\n            - immunodeficiency\n            - splenectomy\n            - skull base fractures\n        - pathogenesis >>>\n            - bacteremia\n            - meningeal invasion\n            - inflammation\n            - potential vasculitis & infarction\n        - clinical manifestations >>>\n            - fever, headache, meningismus, AMS (altered mental status), seizures- most common\n            - nuchal rigidity\n            - petechiae/rash\n            - all these are more common/severe in bacterial meningitis, can be used for differential diagnosis, but definitive with CSF analysis\n        - treatment >>>\n            - rapid initiation of antibiotics (ceftriaxone, vancomycin)\n            - ampicillin for suspected Listeria\n            - duration varies on causative agents\n            - corticosteroids might be beneficial\n    - \n    - \n    - ## aseptic meningitis\n        - common causes >>>\n            - enteroviruses\n            - arboviruses (prof likes tropical diseases remember!)\n        - transmission & RF >>>\n            - fecal-oral route\n            - respiratory droplets\n            - rituximab use (antibodies targeting B cells (healthy & pathogenic))\n            - routes of CNS entry: hematogenous, neural, olfactory\n        - clinical manifestations >>>\n            - fever\n            - headache\n            - photophobia\n            - meningismus (less severe than bacterial)\n            - GI symptoms\n        - treatment >>>\n            - supportive care\n            - antivirals might be considered in severe cases or specific viral infections (e.g. Herpes simplex encephalitis)\n    - \n    - \n    - extras for treatment >>>\n        - seizure management - anticonvulsants\n        - elevated ICP - head elevation, CSF drainage, surgical decompression\n        - prophylaxis - for close contacts of N.meningitidis & H.influenzae\n        - corticosteroids - may reduce mortality & hearing loss in bacterial meningitis (esp. S.pneumoniae & H.influenzae) - administer early, before or with antibiotics\n    - \n    - chronic meningitis >>>\n        - if symptoms over 4 weeks\n        - causes: infectious, autoimmune, neoplastic\n        - diagnosis through history, exam, imaging, CSF analysis, potential biopsy\n    - Mollaret's meningitis >>>\n        - recurrent episodes of aseptic meningitis - lasting 2-5d , separated by weeks to years\n        - often caused by HSV-2\n        - treatment; acyclovir, valacyclovir\n    - \n    - diagnosis >>>\n        - CSF analysis\n            - bacterial meningitis - purulent CSF, â†‘ glucose, â†‘ neutrophils, â†‘ lactate\n            - aseptic meningitis - clear CSF, normal glucose, â†‘ lymphocytes\n        - in general; film array - multiple PCRs at the same time of 2 different targets\n    - \n    - causes of meningitis especially for immunocompromised >>>\n        - Listeria monocytogenes - aseptic meningitis; elderly, newborns, pregnant, immunocompromised \n        - HSV-2 - can cause Mollaret's meningitis; recurrent episodes of aseptic meningitis between years\n        - cryptococcus neoformans - disseminated cryptococcosis\n        - TB - TB meningitis, in HIV/AIDS patients\n- Encephalitis & Myelitis\n    - encephalitis >>>\n        - Inflammation of the brain\n        - resulting from direct invasion from meninges\n        - associated w/ neurological dysfunction\n        - Symptoms: fever, headache, confusion, seizures\n        - Diagnosis: MRI, lumbar puncture\n        - Treatment: antiviral medications, corticosteroids\n    - \n    - myelitis >>>\n        - Inflammation of the spinal cord\n        - often occuring transversely (transverse myelitis)\n        - Symptoms: weakness, sensory changes, bladder dysfunction\n        - Types: transverse myelitis, acute flaccid myelitis\n        - Diagnosis: MRI, lumbar puncture, clinical evaluation\n    - \n    - \n    - epidemiology >>>\n        - low incidence overall\n        - viral infections are the most common cause\n        - higher incidence in children under 1yo & elderly over 65\n        - impact:\n            - prolonged hospitalization\n            - significant mortality\n            - high rates of disability (up to 56%)\n            - early diagnosis & treatment CRUCIAL!\n    - \n    - causes >>>\n        - viral\n            - HSV-1 the most common cause\n            - HSV2 in adults or VZV\n                - acute onset of paralysis in legs\n                - â†“ anal tone\n                - urinary incontinence\n            - CMV\n            - Human Herpesvirus 6 (HHV-6)\n            - West Nile Virus\n                - poliomyelitis-like, acute flaccid paralysis\n            - enteroviruses\n            - HIV\n            - Zika virus\n        - bacterial\n            - less common than viral causes\n            - Listeria monocytogenes\n            - Treponema Pallidym (syphillis)\n        - Fungal - more common in immunocompromised\n        - parasitic - e.g. toxoplasma gondii\n    - autoimmune causes:\n        - autoimmune encephalitis - often involving autoantibodies targeting neuronal receptors or ion channels - paraneoplastic syndromes can auso cause autoimmune encephalitis\n    - HIV status: HIV+; predominance of viral & fungal infections - HIV- predominance of unknown etiology cases\n    - \n    - Routes of entry, to cause pathogenesis >>>\n        - can enter the CNS through several routes\n        - retrograde axonal transport - Herpesviruses (HSV, VZV) -  to reach brain\n        - BBB crossing - some viruses (WNV, VZV) cross BBB directly or indirectly (within WBCs)\n        - olfactory neurons - through olfactory bulb\n        - Blood-CSF barrier crossing: CMV targets endothelial & ependymal cells\n        - Choroid plexus: enteroviruses can enter directly into CSF\n        - Once in CNS, pathogens trigger inflammatory response â‡’ lead to neuronal dmg & neurological dysfunction - inflammatory pattern varies & depends on pathogen\n    - \n    - Clinical manifestations of Encephalitis >>>\n        - classic triad: Headache, nuchal rigidity, fever (fever might be absent)\n        - Altered Mental Status - key feature lasting over 24h\n        - focal neurological signs - depend on area of brain affected - can include ataxia, cranial nerve palsies, seizures, hypothermia, autonomic dysfunction, diabetes insipidus, SIADH [6]\n    - Clinical manifestations of Myelitis >>>\n        - rapid onset: weakness, sensory alterations, bowel/bladder dysfunction\n        - sensory level: defined sensory level helps localize spinal cord lesion\n        - bilateral: typically affects both sides of spinal cord\n        - associated disorders: MS, ADEM (Acute Disseminated EncephaloMyelitis)\n    - \n    - Diagnosis of Encephalitis & Myelitis >>>\n        - Imaging:\n            - MRI - visualize brain & spinal cord Inflammation\n            - CT scan - less precise than MRI - but used if MRI not available\n        - CSF analysis:\n            - pleocytosis - â†‘ WBC count (lymphocytes or neutrophils)\n            - protein levels - often â†‘ \n            - glucose levels - usually normal, but can be â†“ in some infections\n        - EEG - electroencephalogram - detect focal abnormalities, to localize lesion\n        - PCR - highly sensitive for viral DNA or RNA detection in CSF\n    - \n    - Encephalitis & Myelitis treatment >>>\n        - antiviral therapy:\n            - acyclovir - for HSV encephalitis, empirical treatment initiated before PCR results\n            - Ganciclovir - for CMV encephalitis\n            - other antivirals - for other viral causes\n        - Immunotherapies:\n            - corticosteroids - to reduce inflammation in both infectious & autoimmune encephalitis & myelitis\n            - Intravenous Ig - suppress immune response in autoimmune encephalitis\n        - antibiotics:\n            - used for bacterial causes - often given empirically along with acyclovir initially\n    - \n    - \n    - \n    -", "task_type": "study_guide_generation", "subject": "infectious_diseases", "topic": "cns_infections"}
